Your session is about to expire
← Back to Search
Behavioral Intervention
Brief Intervention for Self-Harm in Veterans (STRIVe Trial)
N/A
Waitlist Available
Led By Tate F Halverson, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of treatment, about nine weeks after beginning the study
Awards & highlights
STRIVe Trial Summary
This trial is testing a brief intervention for Veterans who self-harm, with the aim of reducing their distress and self-harming behaviors. It aims to understand how common this behavior is among Veterans, and its link to future suicidal behavior.
Who is the study for?
This trial is for Veterans aged 18 or older who have harmed themselves on purpose at least twice in the past month without suicidal intent. Participants must be fluent in English and able to consent to the study. Those with a history of psychosis, mania, hypomania, or current high risk of suicide or homicide are not eligible.Check my eligibility
What is being tested?
The study is testing a brief intervention designed to reduce self-harm behaviors and improve psychosocial functioning among Veterans. It will compare this new approach against the usual treatment methods typically offered for self-injury.See study design
What are the potential side effects?
As this trial involves psychological interventions rather than medication, traditional side effects are not applicable. However, participants may experience emotional discomfort when discussing self-injurious behavior.
STRIVe Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ end of treatment, about nine weeks after beginning the study
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of treatment, about nine weeks after beginning the study
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility as measured by number of participants enrolled
Feasibility as measured rate of retention
Secondary outcome measures
Number of participants who report satisfaction with the T-SIB treatment
STRIVe Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: T-SIBExperimental Treatment1 Intervention
Participants randomized to the Treatment for Self-Injurious Behaviors (T-SIB) condition will receive nine sessions of T-SIB.
Group II: Treatment As UsualActive Control1 Intervention
Participants randomized to the TAU condition will be provided with referrals to both Durham VA and local community mental health resources and offered a consult for Durham VA mental health services.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,305,244 Total Patients Enrolled
Tate F Halverson, PhDPrincipal InvestigatorDurham VA Medical Center, Durham, NC
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot or do not want to follow the study's required procedures.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment As Usual
- Group 2: T-SIB
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any remaining openings to join this clinical trial?
"After consulting clinicaltrials.gov, it appears that this particular trial does not need new patients as of now; the initial posting was on March 1st 2025 with last modification occurring July 28th 2023. Nevertheless, there are 53 other trials actively recruiting at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger